CYCLERION THERAPEUTICS INC (CYCN)

US23255M2044 - Common Stock

3.38  +0.1 (+3.05%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

CYCLERION THERAPEUTICS INC

NASDAQ:CYCN (12/18/2024, 1:24:10 PM)

3.38

+0.1 (+3.05%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS SubIndustry
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Chartmill High Growth Momentum
EPS Q2Q%
Sales Q2Q%
CRS
6 Month21.93%
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap9.16M
Shares
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts
Short Float %
Short Ratio
IPO
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

CYCN Daily chart

Company Profile

Cyclerion Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of human therapeutics. The company is headquartered in Cambridge, Massachusetts and currently employs 1 full-time employees. The company went IPO on 2019-03-18. The Company’s portfolio includes novel soluble guanylate cyclase (sGC) stimulators, namely praliciguat and olinciguat, as well as multiple research stage molecules. Praliciguat is a systemic sGC stimulator that is licensed to Akebia Therapeutics, Inc. for the treatment of rare kidney disease. Olinciguat is a vascular sGC stimulator that the Company intends to out-license for cardiovascular diseases. The firm operates through the human therapeutics segment. The firm is focused on identifying non-sGC stimulator assets within the central nervous system (CNS) therapeutic area to build a new portfolio. The firm is also evaluating other activities aimed at enhancing shareholder value, which potentially include collaborations, licenses, mergers, acquisitions and/or other targeted investments.

Company Info

CYCLERION THERAPEUTICS INC

301 Binney Street

Cambridge MASSACHUSETTS 02142

P: 16176217722

CEO: Peter M. Hecht

Employees: 1

Website: https://www.cyclerion.com/

CYCN News

News Imagea day ago - Cyclerion Therapeutics, Inc.Cyclerion’s sGC Stimulator Portfolio Generates Revenues to Enable Company Growth

Cyclerion Has Renegotiated Praliciguat License Agreement to Obtain Upfront and Near-Term Payments as well as Entered into a License Option Agreement for Olinciguat

News Imagea day ago - Cyclerion Therapeutics, Inc.Cyclerion’s sGC Stimulator Portfolio Generates Revenues to Enable Company Growth

Cyclerion is leveraging its legacy sGC stimulator assets to generate near-term revenues which will be used to implement its strategic building plan....

ChartMill News Image12 days ago - ChartmillWhich stocks are moving on Friday?

Here are the top movers in Friday's session, showcasing the stocks with significant price changes.

ChartMill News Image13 days ago - ChartmillThe market is buzzing with gapping stocks on Thursday. Let's uncover which stocks are experiencing notable gaps during today's session.

Which stocks are gapping on Thursday?

ChartMill News Image13 days ago - ChartmillWondering what's happening in today's pre-market session? Stay tuned for the latest updates on stock movements.

As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.

ChartMill News Image14 days ago - ChartmillThese stocks are moving in today's after hours session

After the conclusion of the US market's regular session on Wednesday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.

CYCN Twits

Here you can normally see the latest stock twits on CYCN, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example